NCT01067729终止不适用
A Multi-Center, Randomized, Prospective Study of the Treatment of Superficial Partial-Thickness Burns: AWBAT™ vs. Biobrane®
Aubrey Inc.6 个研究点 分布在 1 个国家开始时间: 2009年11月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 试验地点
- 6
- 主要终点
- Rate of healing
研究概览
简要总结
The purpose of this research study is to compare the rate of healing, the infection or complication rate, pain perception and scarring from burn injuries using two types of burn dressings.
详细描述
The purpose of this study is to evaluate AWBAT™ compared to Biobrane® for the treatment of superficial partial-thickness burns using the patient as their own control.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 1 Year 至 70 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Superficial partial thickness burns
- •Two non-contiguous burn sites or the same approximate size/depth for comparison, OR
- •One burn site large enough to accommodate both a 6" square AWBAT™ dressing and a 6 " square Biobrane® dressing
- •Burn wounds measuring >2% - <40% TBSA
- •Patient age: >1 - 70 years
排除标准
- •Ventilator dependence
- •Pregnancy/Lactation
- •Mechanism of injury was electrical, chemical or frostbite
- •Co-morbidity which may compromise healing
- •Known allergy to porcine or porcine products
结局指标
主要结局
Rate of healing
时间窗: Day 14
次要结局
- Scarring(6 months, 1 year, 18 months and 2 years)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
3 期
Ceftobiprole in the Treatment of Patients With Community-Acquired PneumoniaPneumoniaNCT00326287Basilea Pharmaceutica638
已完成
3 期
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast CancerPrimary Breast CancerNCT00793377German Breast Group913
终止
4 期
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot UlcersType II DiabetesNCT02015910Georgetown University1
进行中（未招募）
不适用
A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Cervical Disc Disease at 2 Contiguous LevelsCervical Disc DiseaseNCT04564885Spineart USA300
Unknown
不适用
A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Single Level Cervical Disc DiseaseCervical Disc DiseaseNCT04520776Spineart USA284